Shares of Ceapro Inc. (CVE:CZO – Get Free Report) dropped 11.8% during mid-day trading on Thursday . The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares were traded during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The firm has a 50 day simple moving average of C$0.22 and a 200-day simple moving average of C$0.23. The company has a debt-to-equity ratio of 8.28, a current ratio of 7.10 and a quick ratio of 18.88. The company has a market cap of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
See Also
- Five stocks we like better than Ceapro
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 10 Best Airline Stocks to Buy
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Canadian Penny Stocks: Can They Make You Rich?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
